Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 1997

View Archived Issues

Annual Report: Triangle Pharmaceuticals

TK signal transduction modulators claimed by Sugen

BASF focuses on dolastatin derivatives

Novel anti-HIV compounds disclosed by Novartis

Chiron prepares uPA inhibitors

Human Genome Sciences discloses novel human polypeptide for cancer

Apoptosis-regulating factor discovered

German launch for ACE inhibitor

German introduction for hepatitis vaccine

Third launch for Zyprexa

Comparative study of second-generation t-PA inhibitor and alteplase

GDNF gene therapy for Parkinson's disease

Vaginal antifungal product cleared by FDA

Ampalex trial in AD begins

Magainin lead product licensed to SKB

Labeled SMART antibody shows promise for AML treatment

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...